Bad Soden am Taunus, Germany

Klaus D Kampe

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1989.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Klaus D Kampe: Innovator in Antimycotic Compounds

Introduction

Klaus D Kampe is a notable inventor based in Bad Soden am Taunus, Germany. He has made significant contributions to the field of chemistry, particularly in the development of valuable antimycotic compounds. His work has implications for various applications in pharmaceuticals.

Latest Patents

Klaus D Kampe holds a patent for "2-Azolylmethyl-2-aryl-1,3-dioxolanes and the salts thereof." This patent describes compounds that serve as valuable antimycotics. The patent outlines several preparation processes for these compounds, which include intermediates that are crucial for their synthesis. The compounds are characterized by specific structural features, including variations in the aryl groups and heterocyclic bases.

Career Highlights

Kampe is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at Hoechst has allowed him to focus on innovative solutions in the field of antimycotics. His contributions have been recognized within the industry, showcasing his expertise and dedication to advancing chemical research.

Collaborations

Throughout his career, Klaus D Kampe has collaborated with notable colleagues, including Wolfgang Raether and Heinz Hanel. These collaborations have fostered a productive environment for innovation and have contributed to the successful development of new compounds.

Conclusion

Klaus D Kampe's work in the field of antimycotic compounds highlights his role as an influential inventor. His patent and collaborations reflect his commitment to advancing pharmaceutical research. His contributions continue to impact the industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…